Report overview
Argininemia, also called?arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency?of the enzyme?arginase?causes a buildup of arginine and ammonia in the blood.
This report contains market size and forecasts of Arginase Deficiency Therapeutics in Global, including the following market information:
Global Arginase Deficiency Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Arginase Deficiency Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Arginase Deficiency Therapeutics include Helsinn Healthcare, Novartis Pharmaceuticals, Horizo??n Pharma and Medicis Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Arginase Deficiency Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Arginase Deficiency Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Arginase Deficiency Therapeutics Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
Global Arginase Deficiency Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Arginase Deficiency Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital
Drugs Stores
Other
Global Arginase Deficiency Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Arginase Deficiency Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Arginase Deficiency Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Arginase Deficiency Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Helsinn Healthcare
Novartis Pharmaceuticals
Horizo??n Pharma
Medicis Pharmaceutical
